ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,197Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 617

$610K Total Retail Price of All Prescriptions

Rank: 45 out of 617

420 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 420 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,555 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 549 480 1 2
OMEPRAZOLE 527 464 2 3
WARFARIN SODIUM 385 367 3 7
AMLODIPINE BESYLATE 376 346 4 6
LEVOTHYROXINE SODIUM 297 255 5 1
POTASSIUM CHLORIDE 278 253 6 10
LISINOPRIL 250 235 7 5
FUROSEMIDE 246 212 8 4
METFORMIN HCL 236 204 9 9
METOPROLOL TARTRATE 233 197 10 11
TORSEMIDE 231 217 11 110
TRAMADOL HCL 223 206 12 15
CITALOPRAM HBR 205 182 13 18
HYDROCHLOROTHIAZIDE 194 183 14 13
MELOXICAM 159 145 15 24
DIGOXIN 155 148 16 48
FENTANYL 148 123 S2 17 45
LOSARTAN POTASSIUM 142 126 18 22
HYDROCODONE-ACETAMINOPHEN 137 121 S3 19 8
ZOLPIDEM TARTRATE 129 121 20 23
METOPROLOL SUCCINATE 127 93 21 12
ATENOLOL 127 106 21 17
ENALAPRIL MALEATE 122 72 23 34
CARVEDILOL 119 111 24 19
DIOVAN 119 95 24 41
GABAPENTIN 112 78 26 16
POLYETHYLENE GLYCOL 3350 107 95 27 32
SYNTHROID 105 97 28 59
DONEPEZIL HCL 103 103 29 30
ALENDRONATE SODIUM 98 92 30 25
AZITHROMYCIN 97 79 31 70
ALLOPURINOL 94 93 32 27
GLIPIZIDE ER 90 84 33 94
PREDNISONE 90 87 33 31
CELEBREX 88 88 35 63
DIOVAN HCT 88 84 35 97
ESCITALOPRAM OXALATE 87 80 37 65
PAROXETINE HCL 84 73 38 62
CIPROFLOXACIN HCL 80 68 39 60
RANITIDINE HCL 79 38 40 40
LANTUS 78 72 41 39
SPIRONOLACTONE 76 69 42 42
ADVAIR DISKUS 75 68 43 38
NAMENDA 74 74 44 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 57 45 91
OXYCODONE-ACETAMINOPHEN 72 62 S2 46 93
CEPHALEXIN 71 63 47 68
ATORVASTATIN CALCIUM 70 68 48 14
GLIPIZIDE 69 58 49 82
CLOPIDOGREL 60 53 50 53
GLIPIZIDE XL 60 55 50 147
CARBIDOPA-LEVODOPA 60 60 50 69
PANTOPRAZOLE SODIUM 59 44 53 37
METFORMIN HCL ER 58 44 54 72
NEXIUM 53 40 55 43
JANUVIA 52 43 56 107
SERTRALINE HCL 51 48 57 20
ZETIA 51 41 57 77
VENLAFAXINE HCL ER 50 50 59 76
OXYBUTYNIN CHLORIDE 50 50 59 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.